• Skip to main content
  • Skip to footer
cnb1439_3rs-project_nav-ad_v2
  • About us
  • News
  • Events
  • Careers
cn-bio-organ-on-a-chip-logo
  • Products
    • PhysioMimix® OOC Microphysiological Systems
    • Consumables
      • PhysioMimix® Multi-chip plates
      • 3D validated cells
      • NASH-in-a-box
    • Organ-on-a-chip models
    • Gut/Liver-on-a-chip
    • Lung-on-a-chip
    • Support packages
  • Applications
    • Disease modeling
    • Safety toxicology
    • ADME
  • Services
    • Non-Alcoholic Steatohepatitis
    • Drug-Induced Liver Injury
    • ADME
  • Technology
  • Resources
  • Company
    • About us
    • Events
    • News
    • Careers in Biotech
  • Contact us

Explore our solutions


PhysioMimix® is a suite of hardware, consumables and assay protocols that enable you to recreate complex human biology and accurately predict human drug responses.

PhysioMimix OOC

physiomimix-single-and-multi-organ-on-a-chip-systems
Learn more

Consumables

Multi-chip plates
3D validated cells
NASH-in-a-box
Bioavailability assay kit: Human 18
DILI assay kit: Human 24
Learn more

Models

Single-organ models
- Liver-on-a-chip model
- Lung-on-a-chip model
Multi-organ models
- Gut/Liver-on-a-chip models

Support packages

PhysioMimix® support packages

Discover the applications


Investigate the application areas that our PhysioMimix® products and services support

Learn more

Disease modeling

Metabolic dysfunction-associated steatohepatitis
Hepatitis B
Pulmonary infection
Learn more

Safety toxicology

Drug-induced liver injury
Immune-mediated liver injury
Learn more

ADME

Drug absorption
Drug metabolism
Drug bioavailability
Oligonucleotide delivery
Learn more

Studies as a service


Our team will work collaboratively with you to design a study around your research goals and generate actionable data within weeks

Learn more
icon-nash-1-150x150.png MASLD/MASH
icon-dili-tox-150x150.png Drug-induced liver injury
icon-adme-150x150.png ADME

Fighting Toxic Chemicals: Evaluating the Safety of Cobinamide as a Neutralizing Agent

October 9, 2021

Resource > Webinars >

Fighting Toxic Chemicals: Evaluating the Safety of Cobinamide as a Neutralizing Agent


Evaluating the Safety of Cobinamide as a Neutralizing Agent

Filed under: DILI and Safety toxicology

web s4e3 |

Video content if present

Fighting Toxic Chemicals

Evaluating the Safety of Cobinamide as a Neutralizing Agent


Watch this webinar to learn:

  • Discover more about cross-species hepatotoxicity variability
  • Learn about drug sensitivity in dogs versus other test species
  • Understand the importance of human-relevant drug evaluation

This webinar outlines how Professor Boss’ lab used CN Bio’s Toxicity Testing Services to investigate the hepatotoxicity of two cobinamide formulations. Professor Boss discusses the results of the study, and how the work informed which formulations of cobinamide could be safe for humans.

Professor Gerard Boss’ lab at the University of California San Diego is developing the vitamin B12 analog cobinamide as an antidote against toxic chemicals. Previous research established that cobinamide is well tolerated by mice, rats, rabbits and pigs, but caused hepatotoxicity in dogs. To gain insight into its potential effect in humans, Professor Boss and colleagues wanted to test it against an in vitro primary hepatocyte model.


View our Q&A document from the live event.


Speaker Information:

prof-bossProfessor Gerard R Boss, MD

Distinguished Professor of Medcine,
UCSD

Video content if present

Speak to our experts

Request a meeting with one of our OOC experts to see how our products and services can support your studies

Request a meeting

Footer

CN Bio logo

332 Cambridge Science Park, Milton Road
Cambridge, CB4 0WN

UK: +44 (0) 1223 737 941

US: +1 415 523 4005

Privacy | Cookies | Regulatory | Accessibility
Website terms | Terms of sale

Product Recycling

©2025 CN Bio Innovations Ltd
Registered No. ‍06517359. VAT No. GB978184563

Latest news

  • CN Bio adds computational modelling capabilities to ADME services for enhanced bioavailability profiling September 1, 2025
  • Integrating In Silico Tools with Organ-on-a-Chip to advance ADME studies July 15, 2025
  • NIH to prioritize human-based research technologies & reduce animal use in research July 7, 2025
Cyber Essentials Logo